Key result
Among patients with central nervous system lymphoma, the incidence of venous thromboembolism was 59.5%, with most events occurring during the early period of intensive therapy.
Why the study?
What is the incidence of venous thromboembolism in patients with central nervous system lymphoma?
Population
42 patients with central nervous system (CNS) lymphoma treated between 1992 and 2001
Design
Cohort
Authors
Loading...
High VTE incidence in CNS lymphoma may support prophylaxis evaluation; leaves open efficacy confirmation in randomized trials.
Cohort (n=42)
No
What is the incidence of venous thromboembolism in patients with central nervous system lymphoma?
Patients with CNS lymphoma have a very high incidence of VTE (59.5%), suggesting a potential role for routine anticoagulant prophylaxis during early intensive therapy.
Goldschmidt et al. (2003) conducted a cohort in Central nervous system (CNS) lymphoma (n=42). Central nervous system lymphoma was evaluated on Venous thromboembolism (VTE). Among patients with central nervous system lymphoma, the incidence of venous thromboembolism was 59.5%, with most events occurring during the early period of intensive therapy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: